China SXT Pharmaceuticals, Inc. (SXTC) Ownership
SXTC ownership summary
as of October 18, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 15.00% of shares outstanding
- Shares outstanding
- 10.4M
- Float
- 402K shares available to trade
- Short interest
- 4.96% 66K shares short
- Days to cover
- 0.08 short interest up 0.1% vs prior month
- Insiders 15.00%
- Other investors 85.00%
SXTC top institutional holders
8 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Royal Bank of Canada | <0.01% | 13 | $1 | — | June 30, 2026 |
| 2 | Caitong International Asset Management Co., Limited. | <0.01% | 2 | $0 | +1 (+100.0%) | June 30, 2026 |
| 3 | UBS Group AG | <0.01% | 1 | $0 | — | June 30, 2026 |
| 4 | Amvescap Plc. | 0.00% | — | — | −569 (−100.0%) | March 31, 2026 |
| 5 | Sabby Management LLC | 0.00% | — | — | −78,170 (−100.0%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 0.00% | — | — | −357 (−100.0%) | March 31, 2026 |
| 7 | Tower Research Capital LLC | 0.00% | — | — | −12 (−100.0%) | March 31, 2026 |
| 8 | Citadel Advisors Llc | 0.00% | — | — | −1,003 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 8, 1 holders added 1 shares and 5 cut 80K.
SXTC top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | <0.01% | 356 | $23 | — | May 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
SXTC shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns SXTC
Institutional investors own 0.0% of China SXT Pharmaceuticals's shares and insiders 15.00%. The largest holder is Royal Bank of Canada with <0.01% of the shares (13), as of June 30, 2026. Among the top 8 institutions, 1 added shares and 5 reduced their stake in the latest filings. Short interest is 4.96% of the float, or 0.08 days of average trading volume. The share count rose 5,587.4% since 2017.
Related: SXTC key metrics. See the SXTC stock overview for the latest quote and news.
SXTC ownership FAQ
Who owns the most China SXT Pharmaceuticals stock?
The largest shareholders of China SXT Pharmaceuticals are Royal Bank of Canada (<0.01%), Caitong International Asset Management Co., Limited. (<0.01%), UBS Group AG (<0.01%), Amvescap Plc. (0.00%), Sabby Management LLC (0.00%).
What percentage of China SXT Pharmaceuticals is owned by institutions?
Institutions hold 0.0% of China SXT Pharmaceuticals's shares outstanding; insiders hold 15.00%.
Which funds own China SXT Pharmaceuticals?
The largest fund holders of China SXT Pharmaceuticals are Fidelity Nasdaq Composite Index (<0.01%).
What is China SXT Pharmaceuticals's short interest?
66K shares of China SXT Pharmaceuticals were sold short, 4.96% of the float; at the average daily volume it would take 0.08 days to cover.
How many shares of China SXT Pharmaceuticals are outstanding?
China SXT Pharmaceuticals has 10.4M shares outstanding, of which 402K are in the public float.